The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality

被引:52
作者
Hubacek, JA
Stüber, F
Fröhlich, D
Book, M
Wetegrove, S
Rothe, G
Schmitz, G
机构
[1] Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany
[2] Inst Clin & Expt Med, Prague, Czech Republic
[3] Univ Bonn, Dept Anaesthesiol & Intens Care, D-5300 Bonn, Germany
[4] Univ Regensburg, Dept Anaesthesiol, D-8400 Regensburg, Germany
关键词
sepsis; CD14; polymorphism; infection; lipopolysaccharide;
D O I
10.1038/sj.gene.6363691
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sepsis is characterised by a systemic inflammatory response to bacterial products during infection, which interestingly both in humans and animal models is gender associated with a higher susceptibility of males than females. The CD14 receptor is involved in activation of cells by lipopolysaccharides released from Gram-negative bacteria and, as recently shown, also by products of Gram-positive bacteria (eg, peptidoglycans and lipoleichoic acid). The functional relevance of a C(-159)T CD14 polymorphism recently has been shown based on correlation of the T allele to higher plasma levels of soluble CD14, and higher membrane expression on monocytes. We, therefore, now analysed this CD14 polymorphism in 204 patients with severe sepsis and 247 controls. No significant difference of allele frequencies was observed between sepsis patients and controls neither for males nor females. Mortality also was not associated with the polymorphism studied. This may suggest that other mechanisms for lipopolysaccharide recognition, such as the recently described Toll-like receptors are important for inflammatory cell activation in sepsis.
引用
收藏
页码:405 / 407
页数:3
相关论文
共 37 条
  • [1] Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis
    Astiz, M
    Saha, D
    Lustbader, D
    Lin, R
    Rackow, E
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (06): : 594 - 600
  • [2] A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
    Baldini, M
    Lohman, IC
    Halonen, M
    Erickson, RP
    Holt, PG
    Martinez, FD
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (05) : 976 - 983
  • [3] Tlr4: central component of the sole mammalian LPS sensor
    Beutler, B
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) : 20 - 26
  • [4] MODULATION OF THE ENDOTOXIN RECEPTOR (CD14) IN SEPTIC PATIENTS
    BIRKENMAIER, C
    HONG, YS
    HORN, JK
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1992, 32 (04) : 473 - 479
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis
    Burgmann, H
    Winkler, S
    Locker, GJ
    Presterl, E
    Laczika, K
    Staudinger, T
    Knapp, S
    Thalhammer, F
    Wenisch, C
    ZedwitzLiebenstein, K
    Frass, M
    Graninger, W
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03): : 307 - 310
  • [7] THE 2 SOLUBLE FORMS OF THE LIPOPOLYSACCHARIDE RECEPTOR, CD14 - CHARACTERIZATION AND RELEASE BY NORMAL HUMAN MONOCYTES
    DURIEUX, JJ
    VITA, N
    POPESCU, O
    GUETTE, F
    CALZADAWACK, J
    MUNKER, R
    SCHMIDT, RE
    LUPKER, J
    FERRARA, P
    ZIEGLERHEITBROCK, HWL
    LABETA, MO
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2006 - 2012
  • [8] Binding of bacterial peptidoglycan to CD14
    Dziarski, R
    Tapping, RI
    Tobias, PS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) : 8680 - 8690
  • [9] Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55)
    El-Samalouti, VT
    Schletter, J
    Chyla, I
    Lentschat, A
    Mamat, U
    Brade, L
    Flad, HD
    Ulmer, AJ
    Hamann, L
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 23 (03): : 259 - 269
  • [10] ERTEL W, 1993, SURGERY, V114, P243